Literature DB >> 24871757

Rotavirus vaccination coverage and adherence to recommended age among infants in Flanders (Belgium) in 2012.

T Braeckman1, H Theeten, T Lernout, N Hens, M Roelants, K Hoppenbrouwers, P Van Damme.   

Abstract

In Belgium, rotavirus vaccination has been recommended and partially reimbursed since October 2006. Through a retrospective survey in 2012, we estimated the coverage rate of the rotavirus vaccination in Flanders among infants born in 2010. Using a standardised questionnaire, 874 families were interviewed at home, collecting information on demographic characteristics, socio-economic background and documented vaccination history (updated from medical files and vaccination database, if needed). Adherence to the recommended age for vaccination (8, 12 and 16 weeks) was also assessed. The coverage rate for two doses of rotavirus vaccination was 92.2% (95% confidence interval: 90.2-93.8). Respectively 31.7% and 10.1% of the children received their first and second dose at the recommended age. Incomplete vaccination was often a deliberate choice of the parents. Only eight children (1%) were vaccinated after the maximum age of 26 weeks. Factors identified by multiple logistic regression as related to incomplete vaccination were: living in the province of Antwerp, unemployed mother, and three or more older siblings in the household. Four years after introduction, the coverage rates were surprisingly high for a vaccine that is not fully reimbursed and not readily available in the vaccinator's fridge, which is the case for the other recommended infant vaccines.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24871757     DOI: 10.2807/1560-7917.es2014.19.20.20806

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  11 in total

1.  Facilitators and barriers for use of rotavirus vaccine amongst various stakeholders and its implications for Indian context - A systematic review.

Authors:  Aditi Apte; Sudipto Roy; Ashish Bavdekar; Sanjay Juvekar; Siddhivinayak Hirve
Journal:  Hum Vaccin Immunother       Date:  2018-07-12       Impact factor: 3.452

2.  Vaccination Coverage and Compliance with Three Recommended Schedules of 10-Valent Pneumococcal Conjugate Vaccine during the First Year of Its Introduction in Brazil: A Cross-Sectional Study.

Authors:  Fabricia Oliveira Saraiva; Ruth Minamisava; Maria Aparecida da Silva Vieira; Ana Luiza Bierrenbach; Ana Lucia Andrade
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

3.  The Impact of Socio-Economic Determinants on the Vaccination Rates with Rotavirus and Human Papiloma Virus Vaccine.

Authors:  Urška Grdadolnik; Maja Sočan
Journal:  Zdr Varst       Date:  2015-12-16

4.  Medium- to Long-Term Impact of Rotavirus Vaccination on Hospital Care in Belgium: A 7-Year Follow-Up of the Rotavirus Belgium Impact Study (RotaBIS).

Authors:  Baudouin Standaert; Danielle Strens; Ali Alwan; Marc Raes
Journal:  Infect Dis Ther       Date:  2015-12-31

5.  Improvement in hospital Quality of Care (QoC) after the introduction of rotavirus vaccination: An evaluation study in Belgium.

Authors:  B Standaert; A Alwan; D Strens; M Raes; M J Postma
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  Rotavirus vaccine coverage and factors associated with uptake using linked data: Ontario, Canada.

Authors:  Sarah E Wilson; Hannah Chung; Kevin L Schwartz; Astrid Guttmann; Shelley L Deeks; Jeffrey C Kwong; Natasha S Crowcroft; Laura Wing; Karen Tu
Journal:  PLoS One       Date:  2018-02-14       Impact factor: 3.240

7.  Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic setting.

Authors:  P Bruijning-Verhagen; J A P van Dongen; J D M Verberk; R Pijnacker; R D van Gaalen; D Klinkenberg; H E de Melker; M-J J Mangen
Journal:  BMC Med       Date:  2018-09-10       Impact factor: 8.775

8.  Epidemiological trends for hospital admissions for acute rotavirus gastroenteritis in Belgium following the introduction of routine rotavirus vaccination and the subsequent switch from lyophilized to liquid formulation of Rotarix™.

Authors:  M Raes; D Strens; J Kleintjens; E Biundo; T Morel; A Vyse
Journal:  Epidemiol Infect       Date:  2016-07-04       Impact factor: 2.451

9.  Genome-Wide Evolutionary Analyses of G1P[8] Strains Isolated Before and After Rotavirus Vaccine Introduction.

Authors:  Mark Zeller; Celeste Donato; Nídia Sequeira Trovão; Daniel Cowley; Elisabeth Heylen; Nicole C Donker; John K McAllen; Asmik Akopov; Ewen F Kirkness; Philippe Lemey; Marc Van Ranst; Jelle Matthijnssens; Carl D Kirkwood
Journal:  Genome Biol Evol       Date:  2015-08-08       Impact factor: 3.416

10.  Report of the 5th European expert meeting on rotavirus vaccination (EEROVAC).

Authors:  Marieke L A de Hoog; Timo Vesikari; Carlo Giaquinto; Hans-Iko Huppertz; Federico Martinon-Torres; Patricia Bruijning-Verhagen
Journal:  Hum Vaccin Immunother       Date:  2018-01-18       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.